New gel injection could melt away fatty lumps without surgery

NCT ID NCT07237425

Recruiting now Symptom relief Sponsor: Glonova Pharma Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This early-stage trial tests a new injection called Ronkyla Plus for treating superficial lipomas (fatty lumps under the skin). The drug forms a gel at the injection site, aiming to dissolve the fat more comfortably. The study involves 56 adults and compares Ronkyla Plus to a placebo and an existing treatment (Kybella).

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ronkyla Plus (sodium deoxycholate lipolysis injection forming a hydrogel)
What this could lead to: If successful, this could offer a more comfortable and effective injection treatment for superficial lipomas, reducing the need for surgery.
What could go wrong: This is an early Phase 1 trial with only 56 participants, so safety and effectiveness are not yet proven. The treatment may cause side effects like pain, swelling, or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIPOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lipoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIPOMA SUBMENTAL FULLNESS

Contacts and locations

Locations

Cathay General Hospital
RECRUITING

Taipei, Da'an District, 106436, Taiwan
Cathay General Hospital Sijhih Branch
RECRUITING

New Taipei City, Sijhih District, 22174, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.